| News
Swiss TPH opens new building on the site of BaseLink
04.04.2022
The Swiss Tropical and Public Health Institute has officially opened its multifunctional new building at the Basel Area’s new life sciences hub. On the BaseLink site, up to 10,000 new jobs are being created.

New building "Belo Horizonte" of the Swiss Tropical and Public Health Institute. (img: Joachim Pelikan/Swiss TPH)
The Swiss Tropical and Public Health Institute (Swiss TPH) has combined its departments previously spread across seven buildings into a single new building at the BaseLink site in Allschwil. On April 1, the building, which was designed by Basel-based architects Kunz und Mösch and is known as Belo Horizonte, was officially opened. Across five floors, the new building offers space to house 725 modern workplaces and 150 laboratory places over an area of approximately 13,000 square meters. According to a press release, up to 10,000 new jobs are to be created at the site.
In her address, State Secretary Martina Hirayama praised the institute for making “an important contribution to improving the health of people in Switzerland and around the world” as well as for “driving innovation”. According to the information in the press release, the new building facilitates “attractive forms of interdisciplinary collaboration in order to tackle global challenges and solution approaches in a spirit of partnership”.
Close proximity to Switzerland Innovation Park Basel Area
Director of Swiss TPH, Jürg Utzinger, described the opening of the new building as an historic day for Swiss TPH: “Almost 80 years after our founding we can call this great building our new home”. As such, the “transformation from the so called ‘Tropeli’ to ‘Swiss TPH’ is complete and we can continue to advance our mission of making the world a healthier place”.
According to Nicole Nüssli-Kaiser, Mayor of Allschwil, the new Swiss TPH is an “important anchor institution” at the BaseLink site, where an emerging life sciences in Switzerland cluster is developing. This is situated in close proximity to the Switzerland Innovation Park Basel Area Main Campus, which is set to open in the fall of 2022. Other companies including Abbott, Basilea Pharmaceutica, Idorsia, Johnson&Johnson and Skan have established a presence in the vicinity as well.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read More